Annabel Samimy

Stock Analyst at Stifel

(3.47)
# 928
Out of 4,983 analysts
48
Total ratings
43.75%
Success rate
33.87%
Average return

Stocks Rated by Annabel Samimy

Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $54.51
Upside: -17.45%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $21.79
Upside: +129.46%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $3.63
Upside: +395.87%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20$17
Current: $5.32
Upside: +219.55%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $9.75
Upside: +310.47%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.03
Upside: +156.05%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $10.98
Upside: +118.58%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $9.26
Upside: +331.97%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $23.69
Upside: +237.70%
Jazz Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $225$230
Current: $126.54
Upside: +81.76%
Reiterates: Buy
Price Target: $23$25
Current: $6.52
Upside: +283.44%
Initiates: Buy
Price Target: $35
Current: $17.66
Upside: +98.19%
Maintains: Buy
Price Target: $60$65
Current: $23.82
Upside: +172.88%
Downgrades: Hold
Price Target: $700$275
Current: $11.51
Upside: +2,289.23%
Initiates: Buy
Price Target: $45
Current: $37.42
Upside: +20.26%
Upgrades: Buy
Price Target: $120
Current: $3.57
Upside: +3,261.34%
Initiates: Buy
Price Target: $24
Current: $0.50
Upside: +4,709.62%
Maintains: Buy
Price Target: $700$750
Current: $1.08
Upside: +69,344.44%
Maintains: Hold
Price Target: $25$24
Current: $43.99
Upside: -45.44%